SlideShare una empresa de Scribd logo
1 de 36
Descargar para leer sin conexión
ECG manifestations of drug
overdose
Vera Ruchti
1st
of May 2014
Sir Charles Gairdner Hospital
Emergency Department
Approach to ECG in Toxicology
• rate and rhythm
• PR interval, heart block
• Determine QRS duration in lead II
•Check for right axis deviation of the terminal QRS
•Determine QT interval
•evidence of increased cardiac ectopy or automaticity
•evidence of myocardial ischaemia.
Normal ECG Parameters
• Rate 60-100/minute
• PR: < 200 ms, > 120 ms (3-5 small squares)
• QRS duration: < 100 ms (2.5 small squares)
• QTc interval: < 450 ms
• QTc = QT/ RR1/2
Rate
• Sinustachycardia
– Anticholinergic:
blockade of M2
muscarinic receptors
– Sympathicomimetica
– Serotonin syndrome
• Sinusbradycardia
– Calciumchannel
blockade
– Beta-adrenergic
blockade
– Sodium channel blockers
– Cholinergic syndrome
PR interval heart block
• From beginning of p-wave till beginning of
QRS complex
• PR prolongation is an early sign of Beta- or Ca-
channel blockade
• Significes AV nodal conduction delay
• Drugs:
– Beta blockers, Digoxin, Calcium Channel blockers
Beta blocker overdose
Sodium channel blockade
ECG manifestations of Na channel
blockade
• Bradycardia (ominous sign in TCA toxicity)
• QRS duration > 100 ms measured in lead II
– > 100 ms: seizure
– > 160 ms: ventricular dysrhythmia
• Right axis deviation of the terminal QRS
– Terminal R wave > 3 mm in aVR
– R/S ratio > 0.7 in aVR
Drugs that cause fast sodium channel blockade
• Trycyclic antidepressants
– Amitriptyline
– Desipramine
– Dothiepine
– Imipramine
– nortriptyline
• Class 1A antidysrhythmic agents
– Procainamide
– Quinidine
– disopyramide
• Class 1c antidysrhythmic
– Flecainide
– encainide
• Local anaesthetics
– Bupivacaine
– Cocaine
– ropivacaine
• Pheothiazines
• Amantadine
• Carbamazepine
• Chloroquine
• Diltiazem
• Dephenhydramine
• Hydroxychloroquine
• Propoxyphene
• Propranolol
• quinine
Sodium channel blockade
Prolonged QT interval
• Incidence: unknown
• UK survey: 3 % of total noncardiac
prescription drugs have an official warning of
QT-prolongation
How to measure QT-interval
• Men: > 440 ms
• Women: > 460 ms
• From start of QRS-complex to end of t-wave
• Lead II
• Correction for heart rate:
– Bazett’s square root formula:
– QTc = QT/ RR1/2
– Fridericia’s cube root formula:
– QTc = QT/RR1/3
Pathophysiology of drugs induced QT
prolongation
• Prolongation of action potential: prolongation of
repolarisation.
• Two proposed mechanisms:
– Blockade of Ikr(rapid delayed rectifier channels)
– Abnormal protein trafficking required for the Ikrto the
cell membrane
Why does QT prolongation cause TdP?
• Prolonged repolarisation may result in early after
depolarisation
• M-cells (midventricular myocardcells) show a more
pronounced AP prolongation in response to Ikr
blockade.
• This causes a dispersion of repolisation (heterogenous
recovery of excitability)
• Re-entry, may provoke TdP
• No linear relationship between drug dose and
QT-prolongation
• No relationship between the degree of QT-
prolongation and the likelihood of development
of TdP
• So maybe it is better to measure QT interval
dispersion: maximum-minimum QT-interval, as it
is an indirect measure of spatial heterogeneity of
repolarisation
All drugs are equal, but some drugs are more
equal than others
• Example of amiodarone and sotalol
– Same potent effect on QT prolongation
– Amiodarone:
• No higher risk with higher dose
• incidence of QT prolongation is 0-0.7%, all in patients with
other co-existing risk factors
– Sotalol
• 0.3 % incidence 80 mg
• 3.8 % incidence > 680 mg
• >3.8 mg in patients with risk factors.
Risk factors for QT prolongation/ TdP
• female gender
• Advanced age (> 60 yrs)
• Genetic predisposition
– Congenital long QT syndrome
– Family history of sudden death
– Previous history of drug induced QT-prolongation
• Structural heart disease/ LV dysfunction
• Hypokalemia/severe hypomagnesaemia
– Hyper/hypothyroidism, diabetes
• Absolute or relative bradycardia ( recent conversion from AF)
• Starvation/obesity/ metabolic disorders
• Use of sympathicomimetics
• High drug concentrations:
– Rapid iv-administration
– High dosages
– overdose
QT interval nomogram
Medications that can cause TdP
• Antiarrhythmics
• Calcium channel blockers
• Antimicrobials, including antimalarials,
antifungals
• Antidepressants
• Antispsychotics
• Antiemetics
• Antihistamines
• immunosuppressants
• Antiarrhythmic drugs
• Type 1A (TdP reported in all)
• Quinidine (TdP reported)
• Procainamide (TdP reported)
• Disopyramide (TdP reported)
• Ajmaline (TdP reported)
• Type 1C (increase QT by prolonging QRS interval)
• Encainide
• Flecainide
• Type 3 (TdP reported in all)
• Amiodarone
• Sotalol
• d-Sotalol
• Bretylium
• Ibutilide
• Dofetilide
• Amakalant
• Semantilide
• Calcium channel blockers
• Psychiatric drugs Thioridazine (TdP reported)
• Chlorpromazine (TdP reported)
• Haloperidol (TdP reported)
• Droperidol (TdP reported)
• Amitriptyline
• Nortriptyline
• Imipramine (TdP reported)
• Desipramine (TdP reported)
• Clomipramine
• Maprotiline (TdP reported)
• Doxepin (TdP reported)
• Lithium (TdP reported)
• Chloral hydrate
• Sertindole (TdP reported, withdrawn in the UK)
• Pimozide (TdP reported)
• Ziprasidone
• Antihistamines Terfenadine (TdP reported, withdrawn in the
USA)
• Astemizole (TdP reported)
• Diphenhydramine (TdP reported)
• Hydroxyzine
• Ebastine
• Loratadine
• Mizolastine
• Antimicrobial and antimalarial drugs
• Erythromycin (TdP reported)
• Clarithromycin (TdP reported)
• Ketoconazole
• Pentamidine (TdP reported)
• Quinine
• Chloroquine (TdP reported)
• Halofantrine (TdP reported)
• Amantadine (TdP reported)
• Sparfloxacin
• Grepafloxacin (TdP reported, withdrawn in the UK and USA)
• Pentavalent antimonial meglumine
• Serotonin agonists/antagonists
• Ketanserin (TdP reported)
• Cisapride (TdP reported, withdrawn in the UK and USA)
• Immunosuppressant Tacrolimus (TdP reported)
• Antidiuretic hormone Vasopressin (TdP reported)
• Other agents Adenosine
• Organophosphates
• Probucol (TdP reported)
• Papaverine (TdP reported)
• Cocaine
QT prolongation
Increased cardiac ectopics, increased automaticity
• Ectopics:
– Digoxin, alcohol, cocaine, caffeine, TCA’s
– Autonomic stimulation
• Increased automaticity
– Accelerated juncional rhythm
• Rate 60-120/min
• Retrograde p-waves: inverted in inferior leads, upright
in aVR and V1
• QRS less than 120 ms
– Digoxin toxicity
Accelerated Junctional rhythm
Na/K ATPase pump blockade
• Increased automaticity
• Decreased AV conduction
• Dysrhythmia: supraventricular tachycardia with slow ventricular response
• Frequent PVCs (the most common abnormality), including ventricular bigeminy
and trigeminy
• Sinus bradycardia or slow AF
• Any type of AV block (1st degree, 2nd degree & 3rd degree)
• Regularised AF = AF with complete heart block and a junctional or ventricular
escape rhythm
• Ventricular tachycardia, including polymorphic and bidirectional VT
Digoxin toxicity
Cardiac ischemia
• Tachycardia/ hypotension in pre excisting
coronary artery disease
• Cocaine.
• (remember that cocaine can do all: ischemia,
Na channel blockade and QT prolongation)
• Questions?
My question
• How does Magnesium treat Torsade?
literature
• Medscape: Keeping the Rhythm: hERG and
Beyond in Cardiovascular Safety Pharmacology
• Life in the fast lane
• Toxicology handbook
• Yee Guan Yap & A. John Camm. “Drug induced
QT prolongation and Torsade de pointes. Heart;
Nov:2003:89 (11) 1363-1372
• C. Holstege, D Eldridge, A Rowede. “ECG
manifestations: the poisoned patient”. Emerg.
Med. Clin. N. Ame 24(2006) 159-177

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

CARDIAC ARRHYTHMIAS
CARDIAC ARRHYTHMIASCARDIAC ARRHYTHMIAS
CARDIAC ARRHYTHMIAS
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
Ventricular arrhythmias
Ventricular arrhythmiasVentricular arrhythmias
Ventricular arrhythmias
 
Atrial flutter (AFl) – management principals
Atrial flutter (AFl) – management principalsAtrial flutter (AFl) – management principals
Atrial flutter (AFl) – management principals
 
Wide complex tachycardia drneeraj
Wide complex tachycardia drneerajWide complex tachycardia drneeraj
Wide complex tachycardia drneeraj
 
Antiarrythmic drugs review
Antiarrythmic drugs reviewAntiarrythmic drugs review
Antiarrythmic drugs review
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
 
Acute Coronary Syndrome
Acute Coronary SyndromeAcute Coronary Syndrome
Acute Coronary Syndrome
 
Managing acute coronary syndromes
Managing acute coronary syndromesManaging acute coronary syndromes
Managing acute coronary syndromes
 
AVNRT
AVNRTAVNRT
AVNRT
 
Myocardial infarction (MI) ecg localisation
Myocardial infarction (MI) ecg localisationMyocardial infarction (MI) ecg localisation
Myocardial infarction (MI) ecg localisation
 
Long QT Syndrome
Long QT SyndromeLong QT Syndrome
Long QT Syndrome
 
Atrial Fibrillation by Dr. Aryan
Atrial Fibrillation by Dr. AryanAtrial Fibrillation by Dr. Aryan
Atrial Fibrillation by Dr. Aryan
 
Cardiac Arrhythmias
Cardiac ArrhythmiasCardiac Arrhythmias
Cardiac Arrhythmias
 
Stroke management
Stroke managementStroke management
Stroke management
 
LBBB
LBBBLBBB
LBBB
 
[Int. med] heart murmurs from SIMS Lahore
[Int. med] heart murmurs from SIMS Lahore[Int. med] heart murmurs from SIMS Lahore
[Int. med] heart murmurs from SIMS Lahore
 
Essential hypertension management and treatment
Essential hypertension management  and treatmentEssential hypertension management  and treatment
Essential hypertension management and treatment
 
Wide complex tachycardia
Wide complex tachycardiaWide complex tachycardia
Wide complex tachycardia
 
Management of cardiac arrhythmias
Management of cardiac arrhythmiasManagement of cardiac arrhythmias
Management of cardiac arrhythmias
 

Similar a ECG manifestations of drug overdose

4. ANTI-ARRHYTHMIC.pptx
4. ANTI-ARRHYTHMIC.pptx4. ANTI-ARRHYTHMIC.pptx
4. ANTI-ARRHYTHMIC.pptxHarshikaPatel6
 
Anti arrhytmic drugs lecture
Anti arrhytmic drugs lectureAnti arrhytmic drugs lecture
Anti arrhytmic drugs lectureJavedAkhtar170
 
ANTI ARRYTHMIC DRUGS dr nayak.pdrugssptx
ANTI ARRYTHMIC DRUGS dr nayak.pdrugssptxANTI ARRYTHMIC DRUGS dr nayak.pdrugssptx
ANTI ARRYTHMIC DRUGS dr nayak.pdrugssptxRakshatNayak1
 
anti arrhythmic drugs anaesthesiology cardiac
anti arrhythmic drugs anaesthesiology  cardiacanti arrhythmic drugs anaesthesiology  cardiac
anti arrhythmic drugs anaesthesiology cardiacNeelkantRaju
 
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & PsychiatristEKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & PsychiatristFrank Meissner
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugsChintan Doshi
 
ECG markers in Sudden Cardiac Death
 ECG markers in Sudden Cardiac Death  ECG markers in Sudden Cardiac Death
ECG markers in Sudden Cardiac Death Syed Raza
 
S1 antiarrhythmicdrugs 000 /certified fixed orthodontic courses by Indian den...
S1 antiarrhythmicdrugs 000 /certified fixed orthodontic courses by Indian den...S1 antiarrhythmicdrugs 000 /certified fixed orthodontic courses by Indian den...
S1 antiarrhythmicdrugs 000 /certified fixed orthodontic courses by Indian den...Indian dental academy
 
ANTIARRHYTHMICS.pptx
ANTIARRHYTHMICS.pptxANTIARRHYTHMICS.pptx
ANTIARRHYTHMICS.pptxNeelkantRaju
 
wide complex tachycardia.pptx
 wide complex tachycardia.pptx wide complex tachycardia.pptx
wide complex tachycardia.pptxNakkaSrikanth3
 
pulmonary arterial hypertension in pediatric OPD and ICU
pulmonary arterial hypertension in pediatric OPD and ICUpulmonary arterial hypertension in pediatric OPD and ICU
pulmonary arterial hypertension in pediatric OPD and ICUNeeraj Aggarwal
 
Tachyarrythmias.pdf
Tachyarrythmias.pdfTachyarrythmias.pdf
Tachyarrythmias.pdfGhaiidaakhh1
 
QT INTERVAL IN ECG,CAUSES OF SHORT AND LONG QT INTERVAL
QT INTERVAL IN ECG,CAUSES OF SHORT AND LONG QT INTERVALQT INTERVAL IN ECG,CAUSES OF SHORT AND LONG QT INTERVAL
QT INTERVAL IN ECG,CAUSES OF SHORT AND LONG QT INTERVALDR Venkata Ramana
 
Pharmacology dysrhythmias 2
Pharmacology dysrhythmias 2Pharmacology dysrhythmias 2
Pharmacology dysrhythmias 2shayiamk
 

Similar a ECG manifestations of drug overdose (20)

4. ANTI-ARRHYTHMIC.pptx
4. ANTI-ARRHYTHMIC.pptx4. ANTI-ARRHYTHMIC.pptx
4. ANTI-ARRHYTHMIC.pptx
 
Ecg quiz @ SEMICON 1018
Ecg quiz @ SEMICON 1018Ecg quiz @ SEMICON 1018
Ecg quiz @ SEMICON 1018
 
Anti arrhytmic drugs lecture
Anti arrhytmic drugs lectureAnti arrhytmic drugs lecture
Anti arrhytmic drugs lecture
 
Proarrhythmia
ProarrhythmiaProarrhythmia
Proarrhythmia
 
ANTI ARRYTHMIC DRUGS dr nayak.pdrugssptx
ANTI ARRYTHMIC DRUGS dr nayak.pdrugssptxANTI ARRYTHMIC DRUGS dr nayak.pdrugssptx
ANTI ARRYTHMIC DRUGS dr nayak.pdrugssptx
 
anti arrhythmic drugs anaesthesiology cardiac
anti arrhythmic drugs anaesthesiology  cardiacanti arrhythmic drugs anaesthesiology  cardiac
anti arrhythmic drugs anaesthesiology cardiac
 
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & PsychiatristEKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
 
ECG markers in Sudden Cardiac Death
 ECG markers in Sudden Cardiac Death  ECG markers in Sudden Cardiac Death
ECG markers in Sudden Cardiac Death
 
Arrhytmias
ArrhytmiasArrhytmias
Arrhytmias
 
S1 antiarrhythmicdrugs 000 /certified fixed orthodontic courses by Indian den...
S1 antiarrhythmicdrugs 000 /certified fixed orthodontic courses by Indian den...S1 antiarrhythmicdrugs 000 /certified fixed orthodontic courses by Indian den...
S1 antiarrhythmicdrugs 000 /certified fixed orthodontic courses by Indian den...
 
Anti arrhythmicdrugs
Anti arrhythmicdrugsAnti arrhythmicdrugs
Anti arrhythmicdrugs
 
ANTIARRHYTHMICS.pptx
ANTIARRHYTHMICS.pptxANTIARRHYTHMICS.pptx
ANTIARRHYTHMICS.pptx
 
ECG of the week
ECG of the weekECG of the week
ECG of the week
 
wide complex tachycardia.pptx
 wide complex tachycardia.pptx wide complex tachycardia.pptx
wide complex tachycardia.pptx
 
pulmonary arterial hypertension in pediatric OPD and ICU
pulmonary arterial hypertension in pediatric OPD and ICUpulmonary arterial hypertension in pediatric OPD and ICU
pulmonary arterial hypertension in pediatric OPD and ICU
 
Tachyarrythmias.pdf
Tachyarrythmias.pdfTachyarrythmias.pdf
Tachyarrythmias.pdf
 
QT INTERVAL IN ECG,CAUSES OF SHORT AND LONG QT INTERVAL
QT INTERVAL IN ECG,CAUSES OF SHORT AND LONG QT INTERVALQT INTERVAL IN ECG,CAUSES OF SHORT AND LONG QT INTERVAL
QT INTERVAL IN ECG,CAUSES OF SHORT AND LONG QT INTERVAL
 
Management of svt in adult
Management of svt in adultManagement of svt in adult
Management of svt in adult
 
Pharmacology dysrhythmias 2
Pharmacology dysrhythmias 2Pharmacology dysrhythmias 2
Pharmacology dysrhythmias 2
 

Más de SCGH ED CME

Haemostatic resuscitation
Haemostatic resuscitationHaemostatic resuscitation
Haemostatic resuscitationSCGH ED CME
 
Ultrasound in cardiac arrest
Ultrasound in cardiac arrest Ultrasound in cardiac arrest
Ultrasound in cardiac arrest SCGH ED CME
 
Goals of patient care introduction
Goals of patient care introductionGoals of patient care introduction
Goals of patient care introductionSCGH ED CME
 
Physiology Directed CPR
Physiology Directed CPRPhysiology Directed CPR
Physiology Directed CPRSCGH ED CME
 
Ultrasound confirmation of ETT placement
Ultrasound confirmation of ETT placementUltrasound confirmation of ETT placement
Ultrasound confirmation of ETT placementSCGH ED CME
 
Palliative care in the emergency department
Palliative care in the emergency departmentPalliative care in the emergency department
Palliative care in the emergency departmentSCGH ED CME
 
Wilderness crisis and decision making weekend April 2018
Wilderness crisis and decision making weekend April 2018Wilderness crisis and decision making weekend April 2018
Wilderness crisis and decision making weekend April 2018SCGH ED CME
 
Patient confidentiality in emergency department
Patient confidentiality in emergency departmentPatient confidentiality in emergency department
Patient confidentiality in emergency departmentSCGH ED CME
 
Abscess management
Abscess managementAbscess management
Abscess managementSCGH ED CME
 
Hyperthermia and hypothermia
Hyperthermia and hypothermiaHyperthermia and hypothermia
Hyperthermia and hypothermiaSCGH ED CME
 
It's all about the documentation
It's all about the documentationIt's all about the documentation
It's all about the documentationSCGH ED CME
 
Choosing Wisely - Rational Antibiotic Usage
Choosing Wisely - Rational Antibiotic UsageChoosing Wisely - Rational Antibiotic Usage
Choosing Wisely - Rational Antibiotic UsageSCGH ED CME
 
What's Hot in Emergency Medicine June 2018
What's Hot in Emergency Medicine June 2018What's Hot in Emergency Medicine June 2018
What's Hot in Emergency Medicine June 2018SCGH ED CME
 
Emergency ophthalmology
Emergency ophthalmologyEmergency ophthalmology
Emergency ophthalmologySCGH ED CME
 
Code Brown - Disaster Medicine in the ED
Code Brown - Disaster Medicine in the EDCode Brown - Disaster Medicine in the ED
Code Brown - Disaster Medicine in the EDSCGH ED CME
 

Más de SCGH ED CME (20)

Trauma teams
Trauma teamsTrauma teams
Trauma teams
 
Haemostatic resuscitation
Haemostatic resuscitationHaemostatic resuscitation
Haemostatic resuscitation
 
Arthrocentesis
ArthrocentesisArthrocentesis
Arthrocentesis
 
Ultrasound in cardiac arrest
Ultrasound in cardiac arrest Ultrasound in cardiac arrest
Ultrasound in cardiac arrest
 
Goals of patient care introduction
Goals of patient care introductionGoals of patient care introduction
Goals of patient care introduction
 
Physiology Directed CPR
Physiology Directed CPRPhysiology Directed CPR
Physiology Directed CPR
 
Ultrasound confirmation of ETT placement
Ultrasound confirmation of ETT placementUltrasound confirmation of ETT placement
Ultrasound confirmation of ETT placement
 
Palliative care in the emergency department
Palliative care in the emergency departmentPalliative care in the emergency department
Palliative care in the emergency department
 
Wilderness crisis and decision making weekend April 2018
Wilderness crisis and decision making weekend April 2018Wilderness crisis and decision making weekend April 2018
Wilderness crisis and decision making weekend April 2018
 
Patient confidentiality in emergency department
Patient confidentiality in emergency departmentPatient confidentiality in emergency department
Patient confidentiality in emergency department
 
Abscess management
Abscess managementAbscess management
Abscess management
 
Hyperthermia and hypothermia
Hyperthermia and hypothermiaHyperthermia and hypothermia
Hyperthermia and hypothermia
 
Electrical injury
Electrical injuryElectrical injury
Electrical injury
 
D-dimer audit
D-dimer auditD-dimer audit
D-dimer audit
 
It's all about the documentation
It's all about the documentationIt's all about the documentation
It's all about the documentation
 
Paediatric rashes
Paediatric rashesPaediatric rashes
Paediatric rashes
 
Choosing Wisely - Rational Antibiotic Usage
Choosing Wisely - Rational Antibiotic UsageChoosing Wisely - Rational Antibiotic Usage
Choosing Wisely - Rational Antibiotic Usage
 
What's Hot in Emergency Medicine June 2018
What's Hot in Emergency Medicine June 2018What's Hot in Emergency Medicine June 2018
What's Hot in Emergency Medicine June 2018
 
Emergency ophthalmology
Emergency ophthalmologyEmergency ophthalmology
Emergency ophthalmology
 
Code Brown - Disaster Medicine in the ED
Code Brown - Disaster Medicine in the EDCode Brown - Disaster Medicine in the ED
Code Brown - Disaster Medicine in the ED
 

Último

Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 

Último (20)

Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 

ECG manifestations of drug overdose

  • 1. ECG manifestations of drug overdose Vera Ruchti 1st of May 2014 Sir Charles Gairdner Hospital Emergency Department
  • 2. Approach to ECG in Toxicology • rate and rhythm • PR interval, heart block • Determine QRS duration in lead II •Check for right axis deviation of the terminal QRS •Determine QT interval •evidence of increased cardiac ectopy or automaticity •evidence of myocardial ischaemia.
  • 3. Normal ECG Parameters • Rate 60-100/minute • PR: < 200 ms, > 120 ms (3-5 small squares) • QRS duration: < 100 ms (2.5 small squares) • QTc interval: < 450 ms • QTc = QT/ RR1/2
  • 4. Rate • Sinustachycardia – Anticholinergic: blockade of M2 muscarinic receptors – Sympathicomimetica – Serotonin syndrome • Sinusbradycardia – Calciumchannel blockade – Beta-adrenergic blockade – Sodium channel blockers – Cholinergic syndrome
  • 5. PR interval heart block • From beginning of p-wave till beginning of QRS complex • PR prolongation is an early sign of Beta- or Ca- channel blockade • Significes AV nodal conduction delay • Drugs: – Beta blockers, Digoxin, Calcium Channel blockers
  • 8.
  • 9. ECG manifestations of Na channel blockade • Bradycardia (ominous sign in TCA toxicity) • QRS duration > 100 ms measured in lead II – > 100 ms: seizure – > 160 ms: ventricular dysrhythmia • Right axis deviation of the terminal QRS – Terminal R wave > 3 mm in aVR – R/S ratio > 0.7 in aVR
  • 10. Drugs that cause fast sodium channel blockade • Trycyclic antidepressants – Amitriptyline – Desipramine – Dothiepine – Imipramine – nortriptyline • Class 1A antidysrhythmic agents – Procainamide – Quinidine – disopyramide • Class 1c antidysrhythmic – Flecainide – encainide • Local anaesthetics – Bupivacaine – Cocaine – ropivacaine • Pheothiazines • Amantadine • Carbamazepine • Chloroquine • Diltiazem • Dephenhydramine • Hydroxychloroquine • Propoxyphene • Propranolol • quinine
  • 12.
  • 13. Prolonged QT interval • Incidence: unknown • UK survey: 3 % of total noncardiac prescription drugs have an official warning of QT-prolongation
  • 14. How to measure QT-interval • Men: > 440 ms • Women: > 460 ms • From start of QRS-complex to end of t-wave • Lead II • Correction for heart rate: – Bazett’s square root formula: – QTc = QT/ RR1/2 – Fridericia’s cube root formula: – QTc = QT/RR1/3
  • 15. Pathophysiology of drugs induced QT prolongation • Prolongation of action potential: prolongation of repolarisation. • Two proposed mechanisms: – Blockade of Ikr(rapid delayed rectifier channels) – Abnormal protein trafficking required for the Ikrto the cell membrane
  • 16.
  • 17.
  • 18.
  • 19. Why does QT prolongation cause TdP? • Prolonged repolarisation may result in early after depolarisation • M-cells (midventricular myocardcells) show a more pronounced AP prolongation in response to Ikr blockade. • This causes a dispersion of repolisation (heterogenous recovery of excitability) • Re-entry, may provoke TdP
  • 20. • No linear relationship between drug dose and QT-prolongation • No relationship between the degree of QT- prolongation and the likelihood of development of TdP • So maybe it is better to measure QT interval dispersion: maximum-minimum QT-interval, as it is an indirect measure of spatial heterogeneity of repolarisation
  • 21. All drugs are equal, but some drugs are more equal than others • Example of amiodarone and sotalol – Same potent effect on QT prolongation – Amiodarone: • No higher risk with higher dose • incidence of QT prolongation is 0-0.7%, all in patients with other co-existing risk factors – Sotalol • 0.3 % incidence 80 mg • 3.8 % incidence > 680 mg • >3.8 mg in patients with risk factors.
  • 22. Risk factors for QT prolongation/ TdP • female gender • Advanced age (> 60 yrs) • Genetic predisposition – Congenital long QT syndrome – Family history of sudden death – Previous history of drug induced QT-prolongation • Structural heart disease/ LV dysfunction • Hypokalemia/severe hypomagnesaemia – Hyper/hypothyroidism, diabetes • Absolute or relative bradycardia ( recent conversion from AF) • Starvation/obesity/ metabolic disorders • Use of sympathicomimetics • High drug concentrations: – Rapid iv-administration – High dosages – overdose
  • 24. Medications that can cause TdP • Antiarrhythmics • Calcium channel blockers • Antimicrobials, including antimalarials, antifungals • Antidepressants • Antispsychotics • Antiemetics • Antihistamines • immunosuppressants
  • 25. • Antiarrhythmic drugs • Type 1A (TdP reported in all) • Quinidine (TdP reported) • Procainamide (TdP reported) • Disopyramide (TdP reported) • Ajmaline (TdP reported) • Type 1C (increase QT by prolonging QRS interval) • Encainide • Flecainide • Type 3 (TdP reported in all) • Amiodarone • Sotalol • d-Sotalol • Bretylium • Ibutilide • Dofetilide • Amakalant • Semantilide • Calcium channel blockers • Psychiatric drugs Thioridazine (TdP reported) • Chlorpromazine (TdP reported) • Haloperidol (TdP reported) • Droperidol (TdP reported) • Amitriptyline • Nortriptyline • Imipramine (TdP reported) • Desipramine (TdP reported) • Clomipramine • Maprotiline (TdP reported) • Doxepin (TdP reported) • Lithium (TdP reported) • Chloral hydrate • Sertindole (TdP reported, withdrawn in the UK) • Pimozide (TdP reported) • Ziprasidone • Antihistamines Terfenadine (TdP reported, withdrawn in the USA) • Astemizole (TdP reported) • Diphenhydramine (TdP reported) • Hydroxyzine • Ebastine • Loratadine • Mizolastine • Antimicrobial and antimalarial drugs • Erythromycin (TdP reported) • Clarithromycin (TdP reported) • Ketoconazole • Pentamidine (TdP reported) • Quinine • Chloroquine (TdP reported) • Halofantrine (TdP reported) • Amantadine (TdP reported) • Sparfloxacin • Grepafloxacin (TdP reported, withdrawn in the UK and USA) • Pentavalent antimonial meglumine • Serotonin agonists/antagonists • Ketanserin (TdP reported) • Cisapride (TdP reported, withdrawn in the UK and USA) • Immunosuppressant Tacrolimus (TdP reported) • Antidiuretic hormone Vasopressin (TdP reported) • Other agents Adenosine • Organophosphates • Probucol (TdP reported) • Papaverine (TdP reported) • Cocaine
  • 27. Increased cardiac ectopics, increased automaticity • Ectopics: – Digoxin, alcohol, cocaine, caffeine, TCA’s – Autonomic stimulation • Increased automaticity – Accelerated juncional rhythm • Rate 60-120/min • Retrograde p-waves: inverted in inferior leads, upright in aVR and V1 • QRS less than 120 ms – Digoxin toxicity
  • 29. Na/K ATPase pump blockade • Increased automaticity • Decreased AV conduction • Dysrhythmia: supraventricular tachycardia with slow ventricular response • Frequent PVCs (the most common abnormality), including ventricular bigeminy and trigeminy • Sinus bradycardia or slow AF • Any type of AV block (1st degree, 2nd degree & 3rd degree) • Regularised AF = AF with complete heart block and a junctional or ventricular escape rhythm • Ventricular tachycardia, including polymorphic and bidirectional VT
  • 30.
  • 31.
  • 33. Cardiac ischemia • Tachycardia/ hypotension in pre excisting coronary artery disease • Cocaine. • (remember that cocaine can do all: ischemia, Na channel blockade and QT prolongation)
  • 35. My question • How does Magnesium treat Torsade?
  • 36. literature • Medscape: Keeping the Rhythm: hERG and Beyond in Cardiovascular Safety Pharmacology • Life in the fast lane • Toxicology handbook • Yee Guan Yap & A. John Camm. “Drug induced QT prolongation and Torsade de pointes. Heart; Nov:2003:89 (11) 1363-1372 • C. Holstege, D Eldridge, A Rowede. “ECG manifestations: the poisoned patient”. Emerg. Med. Clin. N. Ame 24(2006) 159-177

Notas del editor

  1. — The arrhythmogenic risk for drug-induced QT prolongation is accurately predicted by the “QT nomogram” which plots QT versus heart rate
  2. Sinustachycardia by increasing depolarisation speed Increased conduction velocity of AV node
  3. — The studies examining QRS duration in tricyclic antidepressant intoxication use manual measurements to measure QRS in limb lead II. -—A large terminal R wave in AVR or increased R/S ratio indicates slow rightward conduction and is characteristic of fast sodium channel blockade. If not pathological, it remains static in appearance and severity throughout the course of the poisoning. Comparison with pre-poisoning ECGs is useful.
  4. Carbamazepine overdose
  5. Historically measured in lead II as the vectors of repolarisation usually result in a long singel wave instead of a discreet t and u wave Fridericia more accurate in extreme phsyciological heart rates. Bazet’s underestimates QT interval at low HR and overestimates at high rates, but Bazett is more frequently used in the literature, so values used from Bazetts formula
  6. Abnormal protein trafficking seen with fluoxetine and digoxin: takes a long time so requires a long exposure to the drugs.
  7. http://quoteko.com/the-action-potential.html
  8. http://www.medscape.com/viewarticle/722090_2
  9. Early after depolarisation by activation of L type Ca channel currents or Na-Ca exchanger (3 na in 1 Ca out) Prolonged repolarisation may result in subsequent activation of inward depolarisation current (early after depolarisation), which may promote triggered activity.
  10. However, Manual measurement of QT interval dispersion is just as inaccurate as manual measurement of QT interval
  11. If point is above the line than the QT-HR is regarded at risk for development of torsade de pointes
  12. Increased automaticity duet o increased intracellular calcium